Pascal and Francis Bibliographic Databases

Help

Search results

Your search

kw.\*:("Therapeutic options")

Publication Year[py]

A-Z Z-A Frequency ↓ Frequency ↑
Export in CSV

Discipline (document) [di]

A-Z Z-A Frequency ↓ Frequency ↑
Export in CSV

Author Country

A-Z Z-A Frequency ↓ Frequency ↑
Export in CSV

Results 1 to 15 of 15

  • Page / 1
Export

Selection :

  • and

Management iatrogener Ösophagusperforationen = Management of iatrogenic esophageal perforationsLAUTERMANN, J; RADECKE, K; SUDHOFF, H et al.HNO. Hals-, Nasen-, Ohrenärzte. 2007, Vol 55, Num 9, pp 723-728, issn 0017-6192, 6 p.Article

Update of current therapeutic options for the treatment of postmenopausal osteoporosisEPSTEIN, Solomon.Clinical therapeutics. 2006, Vol 28, Num 2, pp 151-173, issn 0149-2918, 23 p.Article

Acinetobacter: an old friend, but a new enemyTOWNER, K. J.The Journal of hospital infection. 2009, Vol 73, Num 4, pp 355-363, issn 0195-6701, 9 p.Conference Paper

Alkaloids: Future prospective to combat leishmaniasisMISHRA, Bhuwan B; KALE, Raju R; SINGH, Rakesh K et al.Fitoterapia (Milano). 2009, Vol 80, Num 2, pp 81-90, issn 0367-326X, 10 p.Article

Plantarer ulzerierter Lichen ruber Erfolgreiche Therapie mit Ciclosporin = Ulcerated plantar lichen planus. Successful treatment with cyclosporineRENNEN, R; TREUDLER, R; GEBHARDT, C et al.Der Hautarzt. 2009, Vol 60, Num 8, pp 647-650, issn 0017-8470, 4 p.Article

Eruptive Xanthome bei Hypertriglyzeridämie = Eruptive xanthomas with hypertriglyceridemiaRENNER, R; TEUWEN, I; HARTH, W et al.Der Hautarzt. 2008, Vol 59, Num 12, pp 995-999, issn 0017-8470, 5 p.Article

Prognostic factors and therapeutic options for relapsed or refractory acute myeloid leukemiaFERRARA, Felicetto; PALMIERI, Salvatore; MELE, Giuseppina et al.Haematologica (Roma). 2004, Vol 89, Num 8, pp 998-1008, issn 0390-6078, 11 p.Article

Incorporating anti-IgE (Omalizumab) therapy into pulmonary medicine : Practice practice management implicationsMARCUS, Philip.Chest. 2006, Vol 129, Num 2, pp 466-474, issn 0012-3692, 9 p.Article

Congenital Myasthenic Syndromes: Current Diagnostic and Therapeutic ApproachesSCHARA, Ulrike; DELLA MARINA, Adela; ABICHT, Angela et al.Neuropediatrics. 2012, Vol 43, Num 4, pp 184-193, issn 0174-304X, 10 p.Article

Changing the pathogenetic roadmap of liver fibrosis? Where did it start; where will it go?GRESSNER, Olav A; RIZK, Mohamed S; KOVALENKO, Evgeniya et al.Journal of gastroenterology and hepatology. 2008, Vol 23, Num 7, pp 1024-1035, issn 0815-9319, 12 p.Article

Therapie bei systemischer Sklerodermie : Systemische Sklerodermie = Therapy of systemic sclerosisMEURER, M; REHBERGER, P.Hautarzt. 2007, Vol 58, Num 10, pp 851-857, issn 0017-8470, 7 p.Article

Future treatment options for Gram-positive infections—looking aheadBARTON, E; MACGOWAN, A.Clinical microbiology and infection. Supplement. 2009, Vol 15, Num 6, pp 17-25, issn 1470-9465, 9 p.Conference Paper

Thalidomide prolongs disease stabilization after conventional therapy in patients with recurrent glioblastomaMORABITO, Alessandro; FANELLI, Massimo; CARILLIO, Guido et al.Oncology reports. 2004, Vol 11, Num 1, pp 93-95, issn 1021-335X, 3 p.Article

Valproic acid-associated sialadenosis of the parotid and submandibular glands : Diagnostic and therapeutic aspectsMAUZ, P. S; MÖRIKE, K; KAISERLING, E et al.Acta oto-laryngologica. 2005, Vol 125, Num 4, pp 386-391, issn 0001-6489, 6 p.Article

Review of Recent Results of Montelukast Use as a Monotherapy in Children with Mild AsthmaWAHN, Ulrich; BALACHANDRA DASS, S.Clinical therapeutics. 2008, Vol 30, Num THEM, pp 1026-1035, issn 0149-2918, 10 p., NSArticle

  • Page / 1